Goodwin

Contact
Share
Info
100 Northern Avenue
Boston, MA 02210, United States
Phone: 617.570.1000
Fax: 617.523.1231
Areas Of Practice
  • Antitrust & Trade Regulation
  • Appellate Practice
  • Art, Entertainment, & Sports Law
  • Class Action
  • Criminal Law
  • Energy & Utilities
  • Environmental Law
  • Finance & Banking
  • Government
  • Intellectual Property
  • International Law & Trade
  • Labor & Employment Law
  • Litigation
  • Privacy
  • Products Liability
  • Real Estate
  • Science, Computers, & Tech
  • Securities Law
  • Taxation
  • Toxic Torts
  • Transportation
  • Wills, Trusts, & Estate Planning
See more
Locations
Other U.S. Locations
  • California
  • D.C.
  • Massachusetts
  • New York
Other Countries
  • France
  • Germany
  • Hong Kong
  • United Kingdom
Number of Attorneys
1,000+ Attorneys

The Rise of Agentic AI: From Conversation to Action

The artificial intelligence (AI) landscape is evolving at a dizzying pace. Just as organizations were adapting to generative AI and its capabilities for creating content, a new paradigm has emerged…more
 /  Commercial Law & Contracts, Privacy, Science, Computers, & Technology

CFPB Dismisses Deposit Account Lawsuit Against National Retailer and Fintech Company

The Consumer Financial Protection Bureau voluntarily dismissed its lawsuit with prejudice against a major retailer and a fintech company in the District of Minnesota…more
 /  Consumer Protection, Finance & Banking, Privacy

Maximizing Value in Master-Planned Communities: How to Effectively Negotiate Builder Purchase and Sale Agreements

The investment strategy historically adopted by investors in the US commercial real estate market has transformed notably in recent years, driven in part by evolving patterns in consumer demand and shifting economic conditions…more
 /  Commercial Law & Contracts, Real Estate - Commercial, Real Estate - Residential

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI (ustekinumab-aekn) with STELARA (ustekinumab)

On May 5, 2025, Teva and Alvotech announced that the U.S. Food and Drug Administration (FDA) approved SELARSDI (ustekinumab-aekn) injection as an interchangeable biosimilar to the reference product STELARA (ustekinumab)…more
 /  Health, Science, Computers, & Technology

Crypto Regulatory Framework Begins to Take Shape in Congress

The discussion draft of a new crypto market infrastructure bill proposes a new regulatory framework based on shared jurisdiction between the CFTC and SEC, expanded CFTC authority, and new SEC exemptions for token sales and…more
 /  Finance & Banking, Science, Computers, & Technology, Securities Law

Third Circuit Affirms Rejection of AstraZeneca’s Challenges to IRA Drug Price Negotiation Program

On May 8, 2025, the Court of Appeals for the Third Circuit affirmed the district court’s dismissal of AstraZeneca’s challenges to the Inflation Reduction Act’s Drug Price Negotiation Program and CMS’s Guidance implementing the…more
 /  Administrative Law, Constitutional Law, Health

President Trump Issues Two Executive Orders Concerning the Affordability and Accessibility of Drugs

In the past month, President Trump signed two executive orders concerning drug access and affordability, including for biologics and biosimilar drugs.  On April 15, 2025, President Trump signed Executive Order No. 14273 (“EO…more
 /  Health, Science, Computers, & Technology

Crypto-Assets: AMF Aligns with Six Sets of European Supervisory Guidelines under MiCA Regulation

As part of the implementation of the European Markets in Crypto-Assets Regulation (MiCA), the French Financial Markets Authority (AMF) has announced its compliance with six sets of guidelines adopted by European Supervisory…more
 /  Finance & Banking, International Law & Trade, Securities Law

Trump 2.0’s DOJ: White-Collar Enforcement is Alive and Well

Citing the need to strike a balance between “overbroad and unchecked corporate and white-collar enforcement [that] burdens U.S. businesses and harms U.S. interests” and “[u]nchecked fraud in U.S. markets and government programs…more
 /  Administrative Law, Business Organizations

Further easing the US-UK Divide: Extending the Buy-Side Investment Research Rules to Fund Managers

In our previous alert Paying for Buy-Side Investment Research: New Rules Ease the US-UK Divide | Insights & Resources | Goodwin we discussed the Financial Conduct Authority (FCA) final rules in its policy paper PS24/9: Payment…more
 /  Finance & Banking, International Law & Trade, Securities Law

Antitrust Life Sciences Quarterly Update 2025 Q1

While M&A activity slowed in the first quarter of 2025, including in life sciences, there have been plenty of noteworthy developments in the antitrust space in the first 100 days of the Trump administration…more
 /  Antitrust & Trade Regulation, Health, Science, Computers, & Technology

Antitrust & Competition Healthcare Quarterly Update Q1 2025

While M&A activity has slowed in the tail end of the first quarter of 2025, including in healthcare, there have been several noteworthy developments in the antitrust space in the first 100 days of the Trump Administration…more
 /  Antitrust & Trade Regulation, Mergers & Acquisitions, Health

Regulatory Process for Forming or Acquiring a Depository Institution

This third installment in our series of insights on bank charter considerations describes the process for seeking regulatory approval to form or acquire a bank…more
 /  Finance & Banking

Most Favored Nation Drug Pricing Executive Order Resurrects Prior President Trump Policy

On May 12, 2025, President Trump signed the most recent Executive Order on drug pricing, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients…more
 /  Health, International Law & Trade, Science, Computers, & Technology

Practical Takeaways from the Recently Published EU Foreign Subsidies Decision in Case FS.100011 - e&/PPF

The European Commission has released the full, non-confidential text of its decision in Case FS.100011 – e&/PPF, marking a watershed moment under the EU Foreign Subsidies Regulation (FSR). This is the first case to be cleared…more
 /  Antitrust & Trade Regulation, International Law & Trade
Showing 1-15 of 5748 Results
/
View per page
Page: of 384
This profile may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this profile holder does not constitute a client/attorney relationship. Neither the content on this profile nor transmissions between you and the profile holder through this profile are intended to provide legal or other advice or to create an attorney-client relationship.

"My best business intelligence,
in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide